Why Is North America Leading the Immunodiagnostic System Market?
North America holds a dominant position in the global immunodiagnostic system market, commanding a significant share of both revenue and innovation. With a valuation of USD 12 billion in 2024 and projected growth to USD 18 billion by 2035, the region's leadership is built on advanced healthcare infrastructure, high testing volumes, and the presence of major diagnostic companies. Understanding...
0 Reacties 0 aandelen 244 Views 0 voorbeeld